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Osteoporosis is amultifactorial skeletal disorder characterized by decreased bonemass and deterioratedmicroarchitecture that lead
to increased risk of fracture. The disuse osteoporosis refers to bone mass decrements under conditions of decreased mechanical
loading, including decreased ground force reaction, muscular contraction, and microgravity-related bone loss in astronauts after
space flights. Although there are many eﬀective treatments available for primary osteoporosis, there is a lack of eﬀective treatments
for disuse osteoporosis. This is because that the aetiology, pathophysiology, and resultant pathology of disuse osteoporosis
diﬀer from those of primary osteoporosis. The objective of this paper is to examine the unique pathology and underlying
pathophysiology of disuse osteoporosis.
1. Introduction
Osteoporosis is the condition in which a low bone mass
and altered microarchitecture of the bone leads to increased
risk of fracture. Traditionally, osteoporosis has been clas-
sified into primary and secondary osteoporosis. Primary
osteoporosis refers to osteoporotic conditions which are
not related to other chronic illnesses and is usually asso-
ciated with aging and decreased gonadal function, such as
decreased level of estrogen, whereas secondary osteoporosis
is the type of osteoporosis caused by other health prob-
lems. Disuse is one of the many reasons inducing bone
loss and resulting in secondary osteoporosis [1]. Disuse
osteoporosis has been shown to be a regional phenomenon
in the areas with tremendous decrease in weight bearing
like lower limbs. Bones of lower limbs are subjected to
mechanical stimulations during daily life provided by static
gravity-related weight-bearing, ground reaction forces, and
dynamic loading generated by muscle contractions during
locomotion. Physical exercise is essential for increasing
or maintaining bone mass and strength [2]. Milliken et
al. [3] have investigated the eﬀect of 1-year supervised
weight training exercise on bone mineral density (BMD) in
postmenopausal women. The result showed higher BMDs
of trochanter and femoral neck in women with weight
training exercise than in those lacking exercise. Chan et
al. [4] have studied the eﬀect of Tai-Chi excercise on
bone quality in postmenopausal women. Postmenopausal
women were randomly assigned to an exercise group or a
control group. Subjects in the exercise group performed 5
sessions of 45 minutes Tai-Chi per week. After 1 year of
Tai-Chi exercise, a greater percentage loss in bone density
was observed in the control group when compared to the
exercise group, suggesting that performing Tai-Chi exercise
could decline bone loss in postmenopausal women. Besides,
Feskanich et al. [5] have studied prospectively a cohort on
the relationship between walking, leisure time activity, and
the risk of hip fracture, showing that physical activity was
inversely associated with the risk of hip fracture and that the
eﬀect was dose dependent.
Although there are many eﬀective treatments available
for primary osteoporosis, there is a lack of eﬀective treat-
ments for disuse osteoporosis. This is because of the fact
that the aetiology, pathophysiology, and resultant pathol-
ogy of disuse osteoporosis diﬀer from those of primary
osteoporosis. The objective of this paper is to examine the
unique pathology and underlying pathophysiology of disuse
osteoporosis.
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2. Pathology of Disuse Osteoporosis
Disuse bone loss in general is a reduction of bone mass in
relation to bone volume, while the ratio of bone mineral to
collagen remains unchanged. The loss of trabecular bone is
more rapid and dramatic, while the cortical loss continues
for a longer period [6]. However, bones of lower limbs are
subjected to three categories of mechanical loadings during
daily life, namely, static gravity-related weight bearing,
ground reaction forces, and dynamic loading generated by
muscle contractions during locomotion. Diﬀerent health
problem associates with absence or decrease in one or more
of these mechanical stimulations and will result in bone
loss diﬀerently in anatomical location, quantity, velocity, and
through diﬀerent mechanisms.
Long-term bed rest results in the absence of ground force
reaction and reduction of muscle contractions. Rittweger et
al. [7] have carried out a 35 days bed rest trial and assessed
bone density 2 weeks after the bed rest. They reported
reduction of bone mass in the cancellous bone-rich areas,
1% at distal femur, 3% at patella, and 2% at distal tibia while
no changes in distal radius. The same group has observed
that bone mass in distal radius remained unchanged after
56 days and 90 days bed rest, while bone mass in distal tibia
declined 3.6% and 6% correspondingly [8, 9]. The decreases
of cortical bone thickness and density were below 2% after
as long as 90 days bed rest. These results suggest that long-
term bed rest does not aﬀect balance of bone metabolism
very much.
Disuse osteoporosis includes the reduction of bone mass
after spinal cord injury (SCI) and other brain neurologic
conditions as well. SCI leads to substantial reduction in
ground force reaction and muscle contraction in the lower
limbs resulting in dramatic reduction in bone mass. Result of
a cross-sectional study carried by Garland et al. [10] demon-
strated more than 20% bone loss at distal femur 3 months
after injury in posttraumatic paraplegic and quadriplegic
SCI patients. The researchers reported also that the rate of
bone loss below pelvis was rapid and linear in the acute
stages. In another cross-sectional study with larger sample
size, Kiratli et al. [11] found reduction of bone mineral
density by 27%, 25%, and 43% in femoral neck, mid-shaft,
and distal femur, respectively, compared with the controls.
Beside of SCI, lower limb amputation, acquired brain injury,
and other neurologic conditions can also lead to disabilities
which, in turn, result in disuse osteoporosis. A recent cross-
sectional study by Smith et al. [12] showed that 42.4%
and 23.5% of disabled patients after neurologic traumas,
such as SCI or other conditions for at least 3 months, had
developed osteopenia and osteoporosis, respectively. The
researchers suggested further that ambulatory status and
duration of disability were independent predictors of bone
mineral densities at femoral neck and total proximal femur.
Exposure to microgravity would lead to reduced weight-
bearing and ground reaction forces that result in reduction
in bone mass. Several studies on eﬀects of microgravity on
skeleton focused on the impacts on skeletons of astronauts
after spaceflights. Collet et al. [13] analyzed the BMD and
biochemical parameters of 2 astronauts who stayed 1 and 6
months, respectively, in space. A slight decrease in trabecular
bone mass in distal tibia metaphysis was observed at the end
of the first month of spaceflight, whereas remarkable bone
losses in both trabecular and cortical bones was observed
after 6 months of spaceflight. After 6 month of recovery,
the trabecular bone mass was still significantly lower than
normal, whereas no diﬀerence could be seen in cortical bone.
However, the impacts of microgravity on human skeletons
are highly varied. Another study on 11 astronauts by Vico et
al. [14] showed greater bone losses occurred in cancellous
bone compared to cortical bone. The mean decrease in
cancellous BMD of the 11 astronauts was 5.4% after 6
months of spaceflight but the range of reduction varied from
0.4% to 23.4%. The astronaut who spent the longest time in
space did not have the greatest bone loss.
In comparison of the three causes of disuse osteoporosis,
that is, long-term bed rest, paralysis, and microgravity, all
of them involve the reduction of ground reaction forces and
weight-bearing activities. However, patients with long-term
bed rest or paralysis are further subjected to reduced or even
absence ofmuscular contraction. This situation is diﬀerent in
the case of astronauts whose muscular contractions are not
restricted, and this may be a possible reason account for the
great variations of bone loss in previous findings. Further-
more, muscular contraction can be the most important force
out of the 3 categories of mechanical loading for keeping
bone mass.
3. Pathophysiology of Disuse Osteoporosis
Disuse osteoporosis can be resulted from failure for the bone
to achieve the optimal peak bone mass and strength, if disuse
occurred during the period of bone mass accumulation.
On the other hand, disuse osteoporosis can be the result
of an accelerated rate of bone resorption and slower bone
formation in adults [15].
Ralston [16] indicated that peak bone mass and strength
could be determined by genetic factors which aﬀect the
level of BMD, biochemical markers of bone turnover, and
mechanical properties of bone. Results of association studies
have suggested that polymorphisms of components in the
gene-signaling pathway of genes such as COL1A1, ESR1, and
LRP5 were associated with bone mass level and fracture risk.
The influence of genetic factors on skeletal development is
most pronounced in young people. The impact of genetic
factors diminishes with age because of the increasing impact
of environmental and nutritional factors.
Skeletal growth and repair occur through bone-
remodeling which is a tightly regulated process. The normal
bone mass is maintained during remodeling, based on the
balance between bone formation and bone resorption. The
bone-remodeling cycle begins with the resorption phase
during which osteoclasts are recruited to the remodeling
site on the bone surface, and these osteoclasts will then
excavate the bone surface in the subsequent 2 to 4 weeks.
After the resorption phase, the osteoclasts move away from
the site, and osteoblast precursors move to the site and
diﬀerentiate to become osteoblasts. During the subsequent 2
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Figure 1: Transition electron micrograph of osteoclast-osteoblast
contact in mouse tibial bone marrow (14-week-old male). Arrow-
heads indicate a contact surface between osteoclasts (OC) and
osteoblasts (OB). Scale bar, 5 μm [18].
to 4 months of formation phase, mature osteoblasts deposit
an organ matrix, which will then be mineralized [17].
However, because of certain events such as hormonal changes
at menopause, the balance between bone formation and
resorption is disturbed, and resorption occurs at a higher rate
than that of formation leading to osteoporosis.
Osteoclasts are multinucleated cells derived from mono-
cyte/macrophage lineage (Figure 1) [19] and are the only
type of cells capable of resorbing bone [20]. The rate of
bone resorption is determined by the number and activity of
osteoclasts. During bone resorption, osteoclasts adhere to the
bone matrix forming a deeply folded membrane and secrete
protons and hydrolytic enzymes to the lacuna. The lacuna is
then demineralized by the acidic environment due to proton
secretion, leading to the exposure of organic components
of the bone, such as collagen, to the hydrolytic enzymes,
resulting in degradation of the organic components [21].
Bone resorption is an important physiological process for
bone modeling and remodeling. However, increased rate
of bone resorption may result in the depletion of bone
mass and to disruption of skeletal microarchitecture leading
to skeletal fragility. Receptor activator of nuclear factor
kappaB ligand (RANKL) is a cytokine that belongs to the
TNF family; it is essential for osteoclast formation and
function. RANKL is found on the surface of osteoblasts and
the interaction between RANKL and its receptors RANK
on osteoclast precursors triggers the maturation of osteo-
clasts, thus inducing bone resorption. The RANKL-RANK
interaction is prevented by the natural RANKL inhibitor,
osteoprotegerin (OPG). OPG is also a TNF family member
that binds to RANKL and, hence, inhibits the binding of
RANKL to RANK. Therefore, the activity of osteoclasts is
partially dependent on the balance between RANKL and
OPG (Figure 2) [22]. In addition to RANKL and OPG,
there are many other cytokines such as IL-1, TNF-α and
prostaglandin E2 that have been identified as regulators for
osteoclastic activity [23, 24]. Furthermore, Hughes et al. [25]
showed that estrogen was able to negatively regulate the
formation and function of osteoclast by reducing the lifespan
of the cells by promoting apoptosis. This finding provides
an insight on the cause of postmenopausal osteoporosis.
Osteoclastic bone resorption is a highly regulated process.
However, excessive osteoclastic activity without the comple-
mentary actions by osteoblasts will result in skeletal fragility.
Based on previous studies, it is likely that bone resorption is
influenced by complex interactions between diﬀerent factors
with osteoclasts, and also among the diﬀerent factors.
Skeletal remodeling is the result of both bone resorption
and bone formation. In cases in which the rate of bone
resorption is increased, there could be no apparent bone
loss if the rate of bone formation is matched, since the
bone removed will be replaced by new bone formation.
Osteoporosis is, thus, an imbalance condition where the rate
of bone resorption is higher than the one of bone formation,
resulting in continuous loss of bone and deterioration
of skeletal microarchitecture. Hence, it is important to
determine what factors will aﬀect the rate of bone formation
as well as the coupling process between bone resorption and
formation.
Osteoblasts are mononucleate cells which are responsible
for bone formation. During ossification, or bone forming,
osteoblasts produce an unmineralized, organic portion of the
bone matrix known as osteoid. The osteoids produced will
then mineralize, with minerals such as calcium and zinc, to
form new bone tissue. Osteoblasts arise from mesenchymal
progenitor cells, which possess the master gene of osteoblast
diﬀerentiation, Runx2 (previously known as Cbfa1, Aml3,
or Pebp2a1). In 1997, Komori and coworkers demonstrated
that intramembranous and endochondral ossification were
completely blocked in mice with Cbfa1 gene mutated, where
Cbfa1 was a transcription factor belonging to the Runt-
domain gene family [26]. The same year, Otto et al. showed
that homozygous Cbfa1-deficient mice died of respiratory
failure shortly after birth. In that study, they found that
there was neither osteoblast nor bone in the skeletons of
the homozygous Cbfa1-deficient mice. Also, heterozygous
mutants exhibited specific skeletal abnormalities that were
characteristic of a human heritable skeletal disorder, clei-
docranial dysplasia [27]. These findings suggested that the
Cbfa1 (Runx2) gene is essential for osteoblast diﬀerentiation
and bone formation.
The diﬀerentiation of osteoblasts from mesenchymal
progenitor cells is influenced by growth factors such as
fibroblasts growth factor (FGF), transforming growth factor
beta (TGF-β), and bone morphogenetic proteins (BMPs)
(Figure 3). D’Ippolito et al. [28] pointed out that the number
of osteoblasts tended to decrease as people reach old age.
This leads to the decreased rate of bone formation and
results in osteoporosis. According to a review by Rosen
[29], the insulin-like growth factor (IGF) system is linked
to the process of skeletal acquisition, and IGF-1 is essential
for normal bone formation. Previous study by Sakata et
al. [30] showed that skeletal unloading led to resistant
to the anabolic actions of IGF-I on bone, and this was
associated with the reduction in integrin expression. This
result suggests that IGF-I may be involved in the reaction
mechanism of disuse osteoporosis. Beside of IGF-I, the levels
of various factors and hormones such as BMPs and PTH
have been demonstrated to be changed in response to skeletal
unloading [31]. However, the exact mechanisms of how these
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Figure 2: Regulatory mechanisms of osteoclastogenesis [22].
Colony forming
unit fibroblast
Fibroblasts,
chondrocytes
Preosteoblast
Adipocytes
Osteo-
progenitor
Key:
β-
-
cat
β-cat
β-cat: β-catenin
SFRP: secreted frizzled-related protein
LRP: low-density lipoprotein receptor-
related protein
Dkk: dickkopf
Axin-2: intracellular inhibitor of
canonical Wnt signaling
OsteoblastLining cell
Bone matrix
Osteocyte
Apoptosis
Wnt-10b
Wnt-10b
Axin-2
Axin-2
SFRP-1
SFRP-1
SFRP-1
SFRP-1
LRP-5
LRP-5
LRP-5G171V
Dkk-2
myoblasts, and
Figure 3: Role of canonical Wnt signaling in the control of osteoblastogenesis.
factors respond to changes in mechanical loading are still
unclear.
Sclerostin is the product of the SOST gene that has
been found to bind to LRP5/6 receptors. This binding
inhibits the Wnt signaling pathway and is antagonistic to
bone formation [32]. A recent study by Robling showed
that mechanical stimulation decreased sclerostin expression,
whereas significant increase in SOST expression in tibias
was observed in hindlimb unloaded animals. Thus, the
level of sclerostin, and hence bone formation, appears to
be aﬀected by mechanical stimulation [33]. A recent study
by Lin et al. [34] further suggested that the responses of
bone to mechanical unloading were mediated via sclerostin,
probably by antagonizing Wnt/β-catenin signaling. In the
study, wild-type and SOST knockout mice were unloaded for
2 weeks. Decreased Wnt/β-catenin signaling in association
with increased expression of SOST was observed in wild-type
mice upon unloading. However, in the absence of sclerostin
in SOST −/−mice, decrease in Wnt/β-catenin signaling and
inhibition of osteoblast activity upon unloading were dimin-
ished. The results showed that bone masses of SOST −/−
mice in both loaded and unloaded groups were significantly
higher than those of wild-type groups. More importantly,
unloading-induced bone loss was prevented in SOST −/−
mice, and Wnt/β-catenin signaling, which was shown to
be involved in response to mechanical unloading, was not
altered in unloaded SOST −/− mice. The findings suggest
that sclerostin play an important role in development of
disuse osteoporosis via its action in Wnt/β-catenin signaling.
4. Conclusion
Osteoporosis is a multifactorial skeletal disorder that can be
related to various risk factors. Physical disability, advancing
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age and/or exposure to microgravity increase the risk of
suﬀering from osteoporosis, and such disuse osteoporosis
is associated with huge economic and health burden. On
the other hand, it is an obstacle for space technology
advancement. Understanding the pathology and the under-
lying mechanisms of disuse osteoporosis is important for
the development of new strategies on pharmaceuticals
or treatment protocols for preventing or reducing disuse
osteoporosis. In this paper, the eﬀects of long-term bed
rest, paralysis, and exposure to microgravity on skeletons
were outlined. Also, recent research works on underlying
mechanisms of disuse osteoporosis were described. Certainly,
the entire picture of the pathophysiology of disuse osteo-
porosis is still unclear, but further investigations on action
mechanism of hormones such as IGF-I and antagonists of
sclerostin would provide insights on prospective research
works.
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